HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012

Dec 13, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-12-03

Reporting Person: Gelder Mark S. MD (SVP & Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$.5301	2022-12-03	Common Stock (4000000)		Direct

Footnotes

F1: Options will vest with respect to 1/4 of the underlying shares on December 3, 2013 and 1/36 of the remaining underlying shares monthly thereafter so that the options are fully vested on the fourth anniversary of the date of grant.